nLIGHT LASR 深 沪
已收盘 11-13 16:00:00 美东时间
41.25
-1.810
-4.20%
华盛通- 最 高43.11
- 今 开42.90
- 成交量 54.76万股
- 最 低 40.815
- 昨 收 43.06
- 总市值 24.02亿
- 52周最高 86.95
- 市盈率 静 --
- 换手率 0.94%
- 52周最低 28.695
- 委 比 95.03%
- 总股本 5823.41万
- 历史最高 86.95
- 量 比 0.37
- 振 幅 5.33%
- 历史最低 6.20
- 每 手 1
- 风险率 14.97%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Candel Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
Candel Therapeutics reported Q3 2026 financials with $203.1M in cash, supporting operations into Q2 2028. The company advanced its aglatimagene BLA submission timeline to mid-2027, pending FDA dialogue. Clinical updates included promising data across prostate cancer, NSCLC, and recurrent glioma. The company also appointed key executives to strengthen its commercial readiness.
11-12 21:05
Nlight Inc.收涨1.09%，成交额3707.66万美元
11月12日，Nlight Inc.（LASR）收涨1.09%，报44.48美元，成交额3707.66万美元，市值25.9亿美元。 行情数据 • 开盘价：45...
11-12 06:21
Nlight Inc.2026财年第3季度营收7376.3万美元，同比增长10.52%
最新财报显示，Nlight Inc.2026财年第3季度实现： 营业收入：7376.3万美元 同比：增长10.52% 每股收益：-0.12美元 同比：增长9....
11-07 10:00
Moderna, JFrog, TransMedics, Ubiquiti And Other Big Stocks Moving Higher On Friday
U.S. stocks were mostly higher, with the Nasdaq Composite gaining around 400 points on Friday. Shares of Moderna Inc (NASDAQ:MRNA) rose sharply after the company reported better-than-expected third-quarter financial results and raised its FY26 sales guidance above estimates. Moderna reported quarter...
11-06 23:51
Why Cloudflare Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Shares of Cloudflare, Inc. (NYSE:NET) rose sharply in pre-market trading after the company reported better-than-expected third-quarter financial results. Cloudflare reported third-quarter revenue of $782.513 million, up 39% year-over-year. The revenue total beat a Street consensus of $738.532 millio...
11-06 18:23
nLight Q3 2026 Earnings Call Transcript
nLight (NASDAQ:LASR) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis...
11-06 06:37
nLight Sees Q4 Sales $84.000M-$90.000M vs $75.113M Est
nLight (NASDAQ:LASR) sees Q4 sales of $84.000 million-$90.000 million vs $75.113 million analyst estimate.
11-06 05:51
Disc Medicine Reports Third Quarter 2026 Financial Results and Provides Business Update
Disc Medicine reported positive results from the Phase 3 APOLLO trial of bitopertin in erythropoietic protoporphyria (EPP), meeting all primary and secondary endpoints. The company plans to resubmit a New Drug Application (NDA) by end-2026, with an FDA decision expected mid-2027. Additionally, Disc presented encouraging data from the Phase 2 RESTORE-PV study of DISC-3405 in polycythemia vera (PV) and plans to share updated results at the ASH annu...
11-05 13:30
